GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Net Margin %

PEPTONIC medical AB (XSAT:PMED) Net Margin % : -98.61% (As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. PEPTONIC medical AB's Net Income for the three months ended in Mar. 2024 was kr-10.66 Mil. PEPTONIC medical AB's Revenue for the three months ended in Mar. 2024 was kr10.81 Mil. Therefore, PEPTONIC medical AB's net margin for the quarter that ended in Mar. 2024 was -98.61%.

The historical rank and industry rank for PEPTONIC medical AB's Net Margin % or its related term are showing as below:

XSAT:PMED' s Net Margin % Range Over the Past 10 Years
Min: -112188.89   Med: -232.87   Max: -84.47
Current: -115.87


XSAT:PMED's Net Margin % is ranked worse than
85.97% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.17 vs XSAT:PMED: -115.87

PEPTONIC medical AB Net Margin % Historical Data

The historical data trend for PEPTONIC medical AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Net Margin % Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -556.01 -146.09 -232.87 -84.47 -114.74

PEPTONIC medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -90.13 -62.70 -78.66 -289.04 -98.61

Competitive Comparison of PEPTONIC medical AB's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PEPTONIC medical AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PEPTONIC medical AB's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PEPTONIC medical AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where PEPTONIC medical AB's Net Margin % falls into.



PEPTONIC medical AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

PEPTONIC medical AB's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-42.589/37.118
=-114.74 %

PEPTONIC medical AB's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-10.658/10.808
=-98.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PEPTONIC medical AB  (XSAT:PMED) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


PEPTONIC medical AB Net Margin % Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PEPTONIC medical AB (XSAT:PMED) Business Description

Traded in Other Exchanges
Address
Gustavslundsvägen 143, Bromma, SWE, SE-167 51
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB (XSAT:PMED) Headlines

No Headlines